Evaluation of efficacy and safety of rivaroxaban combined with aspirin in patients with chronic coronary artery disease: A protocol for systematic review and meta-analysis

BACKGROUND: Coronary artery disease (CAD) is among the main causes of morbidities and mortalities globally. It is also considered to be an outcome of acute thrombotic events which entail activating platelets as well as coagulation proteins. In particular, rivaroxaban along with aspirin have been con...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Han, Li, Xiuqi, Wu, Xingan, Wu, Huiting, Xie, Gang, Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
3900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830853/
https://www.ncbi.nlm.nih.gov/pubmed/35147105
http://dx.doi.org/10.1097/MD.0000000000028779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830853/
https://www.ncbi.nlm.nih.gov/pubmed/35147105
http://dx.doi.org/10.1097/MD.0000000000028779

Ejemplares similares